Cue Biopharma, Inc. (CUE) (CIK 0001645460) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001193125-26-129018
- Form
- CORRESP
- Filer
- Cue Biopharma, Inc. (CUE) (CIK 0001645460)
- CIK
- 0001645460
- Ticker
- CUE
- Filed
- 2026-03-27
- SIC industry
- 2834
- HQ
- Boston, MA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1645460/000119312526129018/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer